Istituto di Candiolo IRCCS - Fondazione del Piemonte per l'Oncologia

Torino 10060

1 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Melanoma, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma — Completed